- Home
- NUWE vs AKAN Comparison
NUWE vs AKAN Comparison
Compare NUWE & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUWE | AKAN |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | United States | Canada |
| Employees | 38 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NUWE | AKAN |
|---|---|---|
| Price | $1.66 | $0.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 165.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.42 |
| 52 Week High | $25.95 | $9.29 |
Technical Indicators
Market Signals| Indicator | NUWE | AKAN |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 47.11 |
| Support Level | $0.20 | $0.84 |
| Resistance Level | $2.09 | $1.42 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 2.04 | 43.95 |
Price Performance
Historical ComparisonAbout NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.